Histogenetisch bedingte Sternmusterungen an Petalen treten in verschiedenen Pflanzengattungen auf und konnten bei Camellia, Pelargonium, Phlox, Rhododendron, Saintpaulia und Verbena nachgewiesen werden, sie sind aber auch bei Myosotis und Petunia bekannt. Die Sternmusterungen entstehen bei den untersuchten Sorten durch Anthocyandefektmutation in einer bestimmten Sproßscheitelschicht und den abstammenden Geweben, in Abhängigkeit von der gewebespezifischen Farbstoffbildung im Blütenblatt, dem Wirken der Partnerinduktion von anthocyanintaktem auf anthocyandefektes Gewebe (Induktion der Anthocyansynthese) und der L1-Beteiligung an der Mesophyllbildung des Blütenblattrandes. Fünf unterschiedliche Typen der histogenetisch bedingten Sternmusterbildung in der Petalenfärbung unter Berücksichtigung dieser Charakteristika konnten gefunden werden. / Histogenetically determined pinwheel patterns in petals exist in various genera of plants. Such patterns have been proved in Camellia, Pelargonium, Phlox, Rhododendron, Saintpaulia and Verbena, and are also known in Myosotis and Petunia. Pinwheel patterns occur by mutation in a defined layer of the apex and ist originated tissues. Its intensity is affected by presence of pigmentation in specific tissues of the petal and the existance and level of partner- induction (induction of anthocyanin synthesis from anthocyan-intact to anthocyan-defect tissue), and the participation of L1 (layer one of the apex) on the formation of mesophyll in the margin of the petal. Five different types of the histogenetically determined formation of pinwheel patterns were found according to the above mentioned conditions. In addtion, some other types can exist when more than two layers of the apex and their derived tissues form the petals (perhaps in Camellia) and layer 2 and 3 are different in their genotypes.

Die vorliegende Arbeit befasst sich mit züchtungsmethodischen Untersuchungen zur Schaffung blattvariegater Pelargonium x zonale-Hybriden auf tetraploidem Leistungsstand. Basierend auf dem Wirkstoff Trifluralin konnte eine effektive Behandlungsvariante zur somatischen Polyploidisierung periklinalchimärischer Pelargonium x zonale-Klone etabliert werden. Unter Ausnutzung biparentaler Erbgänge wurden fünf ausgewählte Plasmotypen an das Leistungsniveau moderner Sortimente herangeführt. Daneben erbrachten Kreuzungen innerhalb der Sektion Ciconium hybridvariegate F1-Pflanzen. Die Möglichkeit der Ausnutzung von Kern-Plasma-Wechselwirkungen in der Pelargonienzüchtung wird diskutiert. Im Hinblick auf den Aufbau eines Protoplastenregenerationssystems konnten Zellsuspensionskulturen etabliert werden. Im Anschluss an enzymatische Verdauungen wurde die Regeneration von Kallus beobachtet. Variegate Pflanzen aus Mutationsversuchen mit NMH (Nitroso-Methyl-Harnstoff), einer weiteren experimentellen Variante, erwiesen sich als steril, so dass eine weiterführende Züchtungsarbeit auf diesem Weg bisher noch nicht möglich war / The study analyzes breeding schemes concerning the development of variegated tetraploid Pelargonium x zonale-hybrids (Pelargonium x hortorum). With a focus on practical relevance breeding methods for periclinal chimeric leaf patterns are discussed. Trifluralin-induced tetraploid Pelargonium x zonale-hybrids were successfully crossed with modern cultivars. Via biparental mode of inheritance five defined plasmotypes were transfered to the karyological background of current high-performance Pelargonium series. In a crossing-program within the section Ciconium hybrid-variegation was detected. The possibility of using nucleo-plasmatic interactions in developing new Pelargonium cultivars is discussed. First steps concerning a biotechnological approach to create variegated plants included the establishment of cell-suspension-cultures as the base for a protoplast regeneration system. Following the enzymatic digestion of Pelargonium-liquid cultures up to now, callus regeneration was achieved. Variegated plants resulting from mutagenic treatments with NMU (Nitroso-methylurea) proved to be sterile.

In this thesis, store separation from two different configurations are solved using computational methods. Two different commercially available CFD codes / CFD-FASTRAN, an implicit Euler solver, and an unsteady panel method solver USAERO, coupled with integral boundary layer solution procedure are used for the present computations. The computational trajectory results are validated against the available experimental data of a generic wing-pylon-store configuration at Mach 0.95. Major trends of the separation are captured. Same configuration is used for the comparison of unsteady panel method with Euler solution at Mach 0.3 and 0.6. Major trends are similar to each other while some differences in lateral and longitudinal displacements are observed. Trajectories of a fueltank separated from an F-16 fighter aircraft wing and full aircraft configurations are found at Mach 0.3 using only the unsteady panel code. The results indicate that the effect of fuselage is to decrease the drag and to increase the side forces acting on the separating fueltank from the aircraft. It is also observed that the yawing and rolling directions of the separating fueltank are reversed when it is separated from the full aircraft configuration when compared to the separation from the wing alone configuration.

Onchocerciasis is a severely debilitating yet neglected tropical disease (NTD) currently affecting approximately 15.5 million people, including 12.2 million people with skin disease and 1.025 million with vision loss. The disease causes social stigma, generates and perpetuates poverty, and leads ultimately to irreversible unilateral or bilateral blindness if untreated. Consequently, onchocerciasis is a major impediment to socioeconomic development in addition to being a major public health concern in some African countries. Many control programs have been launched against the disease with moderate successes achieved in Africa. These limited outcomes are partially due to the unavailability of reliable, non-invasive and easily applicable diagnostic tools for mapping endemic regions, monitoring control program successes, determining treatment endpoints and post-elimination surveillance. The current WHO recommendations for certification of elimination include the use of the Ov16 antibody detection ELISA which is flawed by an intrinsic systematic error as 15-25% of infected populations may not produce antibodies against this antigen due to genetic restrictions. With the recent shift in the global health goal of onchocerciasis from control to elimination, there is a need for the development of novel appropriate tools. These tools include amongst others, drugs, diagnostics, and vaccines. In this work, bioinformatics analyses combined with immunological assays were applied in a bid to develop potential tools for the current elimination programs. With regards to chemotherapy, Ivermectin which has been the sole drug for onchocerciasis treatment for over 30 years kills only the microfilariae (mf) leaving the adult worms intact which continue to produce the mf. Moreover, there is a recent problem of development of parasite resistance to this drug. In addition, moxidectin which was recently approved for treatment is contra-indicated in pregnant women and children under 12 who could continue to serve as reservoirs for infection. There is therefore a need to develop new treatment strategies, preferably for macrofilaricidal drugs. For a total eradication of onchocerciasis, diagnosis and treatment must be complemented with vaccine development. The aim of this work was therefore (i) to characterise an O. volvulus antigen, Ov58GPCR and (ii) to design an epitope-based chimeric antigen, which we designated, Ov-DKR-1, within the framework of the development of onchocerciasis control tools. In order to achieve the first goal, towards diagnosis, synthetic peptides representing linear B-epitopes and the recombinant extracellular domain of a G-protein coupled receptor (GPCR) with diagnostic potential were tested for their immune responses using serum from onchocerciasis-infected individuals and various controls. The results obtained indicate that (i) the O. volvulus antigen, Ov58GPCR is a G-protein coupled receptor (GPCR) conserved in related nematodes, (ii) synthetic peptides predicted to be in the extracellular domain (ECD) of Ov58GPCR are indeed immunogenic epitopes in onchocerciasis-infected individuals, (iii) synthetic peptide cocktails discriminate between actively-infected individuals, treated non-infected individuals and healthy African controls, (iv) polyclonal antibodies against one of the peptides or against the bacterially-expressed ECD reacted specifically with the native antigen in O. volvulus total and surface extracts, (v) Ov58GPCR is transcribed in both larvae and adult parasite stages, (vi) IgG and IgE responses to the recombinant ECD decline with Ivermectin treatment. All these findings suggest that the recombinant extracellular domain and synthetic peptides of Ov58GPCR, as well as the specific immune responses generated, could be harnessed in the context of disease diagnosis and surveillance. To assess the potential role of Ov58GPCR in drug or vaccine target development, preliminary examination on the essentiality of the Ov58GPCR for parasite survival was evaluated through RNA interference. A short-interfering RNA (siRNA) sequence targeting the gene designed and tested by soaking with O. volvulus male worms resulted in a reduction in motility. Results indicated that the gene may be involved primarily in motility. Further investigations are recommended in this light. With regards to the second goal, towards the development of a potential immune-protective tool, many indicators reveal the possibility of the development of protective tools against onchocerciasis. Consequently, an immuno-informatics approach was applied to design a filarial-conserved multi-epitope subunit vaccine candidate consisting of B-and T-cell epitopes of proteins reported to be potential novel vaccine candidates. Conservation of the selected proteins in other nematode parasitic species and predicted epitopes suggests that the generated chimera protein (Ov-DKR-1) could be vital in cross-protection. The 3D structure was predicted, refined and validated bioinformatically. Protein-protein docking of the chimeric vaccine candidate with the TLR4 receptor predicted efficient favourable binding. Immune simulation predicted significantly high levels of IgG1, T-helper, T-cytotoxic cells, INF-γ, and IL-2 responses. Overall, the designed chimeric peptide demonstrated antigenicity superior to the current vaccine candidates. / L’onchocercose est une maladie tropicale sévèrement débilitante mais négligée qui touche actuellement environ 15,5 millions de personnes, dont 12,2 millions de souffrant de maladies de la peau et 1,025 millions de souffrant de perte de vision. La maladie provoque une stigmatisation sociale, génère et perpétue la pauvreté et finit par conduire à une cécité unilatérale ou bilatérale irréversible si elle n'est pas traitée. En conséquence, l’onchocercose est un obstacle majeur au développement socioéconomique en plus d’être une préoccupation majeure pour la santé publique. De nombreux programmes de lutte ont été lancés contre la maladie, avec quelques succès en Afrique. Ces résultats sous-optimaux (limités) sont en partie dus à l’absence d’outils fiables, non invasifs et facilement applicables pour la cartographie des régions endémiques, le suivi des succès des programmes de contrôle, la détermination des paramètres de traitement et la surveillance post-élimination. Les recommandations actuelles de l’OMS pour la certification de l’élimination incluent l’utilisation du test ELISA de détection d’anticorps Ov16, entaché d’une erreur systématique intrinsèque puisque 15 à 25% des populations infectées peuvent ne pas produire d’anticorps contre cet antigène en raison de restrictions génétiques. Avec l’évolution récente de l’objectif de santé mondial de l’onchocercose de passé de la lutte à l’élimination, il est donc nécessaire de mettre au point de nouveaux outils appropriés. Ces outils nécessaires incluent, entre autres, des médicaments, des diagnostics et des vaccins. Dans ce travail, des analyses bio-informatiques combinées à des tests immunologiques ont été appliquées dans le but de développer des outils potentiels pour les programmes d'élimination actuels. En ce qui concerne la chimiothérapie, l’ivermectine, qui est le seul médicament utilisé depuis plus de 30 ans pour le traitement de l’onchocercose, ne tue que les microfilaires (mf) laissant intacts les vers adultes qui continuent à produire le mf. A ceci joint, il y a le problème récent du développement de la résistance des parasites à ce médicament. En outre, un traitement récemment approuvé, la moxidectine, est contre-indiquée chez les femmes enceintes et les enfants de moins de 12 ans qui pourraient continuer à servir de réservoirs d’infection. Il est donc absolument nécessaire d’élaborer de nouvelles stratégies de traitement, de préférence pour les médicaments macrofilaricides. Pour une éradication totale de l’onchocercose, le développement du vaccin doit être complété par le diagnostic et le traitement. Le but de ce travail est donc de caractériser un antigène d'O. volvulus, Ov58GPCR et de concevoir un antigène chimérique à base d'épitope, que nous avons appelé Ov-DKR-1, dans le cadre du développement d'outils de contrôle de l'onchocercose.Concernant le premier objectif, des peptides synthétiques représentant des épitopes B linéaires et le domaine extracellulaire (DEC) recombinant d'un récepteur couplé à la protéine G (GPCR) présentant un potentiel diagnostique ont été testés pour déterminer leur réponse immunitaire en utilisant du sérum d'individus infectés par l'onchocercose et divers témoins. Les résultats obtenus indiquent que (i) l'antigène d'O. volvulus, Ov58GPCR est un récepteur couplé à la protéine-G (GPCR) conservé dans les nématodes apparentés (ii) les peptides synthétiques prédits comme localisés dans le domaine extracellulaire de Ov58GPCR sont bien des epitopes immunogéniques chez les individus infectés par l’onchocercose, (iii) les cocktails de peptides synthétiques établissent une distinction entre les individus activement infectés avec l’onchocercose, les individus non-infectés traités et les témoins africains en bonne santé, (iv) les anticorps polyclonaux contre un des peptides ou le domaine extracellulaire exprimé au bactéries réagisent spécifiquement avec l'antigène natif dans les extraits total et de surface d'O. volvulus, (v) Ov58GPCR est transcrit aux stades larvaire et adulte, (vi) les niveaux détectés d’IgG et IgE grâce à le DEC recombinant diminuent au cours du traitement par l'ivermectine. Toutes ces découvertes suggèrent que le domaine extracellulaire recombinant et les peptides synthétiques de Ov58GPCR, ainsi que les réponses immunitaires spécifiques générées, pourraient être exploités dans le contexte du diagnostic et de la surveillance de la maladie. Pour évaluer le rôle potentiel d’Ov58GPCR dans le développement de médicaments ou de vaccins cible, un examen préliminaire de l’indispensabilité du gène Ov58GPCR pour la survie du parasite a été évalué par interférence d’ARN. Une séquence d'ARN interférant court (ARNic) ciblant le gène conçu et testé par trempage avec des vers mâles d'O. volvulus a entraîné une réduction de la motilité. Les résultats ont indiqué que le gène pourrait être impliqué principalement dans la motilité. Des investigations complémentaires sont recommandées dans cette optique.Concernant le deuxième objectif, de nombreux indicateurs révèlent la possibilité de développer des outils de protection contre l’onchocercose. En conséquence, une approche immuno-informatique a été appliquée pour concevoir un candidat-vaccin des sous-unités de multi-épitopes conservées-filarienne consistant des épitopes de cellules B et T de protéines qui seraient de nouveaux candidats vaccins. La conservation des protéines sélectionnées chez d'autres espèces parasitaires de nématodes et d'épitopes prédits suggère que la protéine chimère générée (Ov-DKR-1) pourrait être vitale pour la protection croisée. La structure 3D a été prédite, raffinée et validée bioinformatiquement. La fixation protéine-protéine du candidat vaccin chimère au récepteur TLR4 prédit une liaison favorable efficace. La simulation immunitaire prédit des niveaux significativement élevés d'IgG1, de réponses T-helper, de cellules T-cytotoxiques, de INF-γ et d'IL-2. Globalement, le peptide chimère conçu a démontré une antigénicité supérieure aux candidats vaccins actuels. / Option Biologie moléculaire du Doctorat en Sciences / info:eu-repo/semantics/nonPublished

Made available in DSpace on 2016-06-02T20:21:31Z (GMT). No. of bitstreams: 1 5135.pdf: 1934880 bytes, checksum: 392e2dc3d6c55b9eb87de4bb33adec6d (MD5) Previous issue date: 2013-02-05 / Universidade Federal de Sao Carlos / The sugarcane bagasse is a lignocellulosic material that can be converted into ethanol by action of cellulases and xylanases. These enzymes act synergistically to convert cellulose and hemicellulose into glucose. In order to obtain an enzyme that can perform dual function, a chimeric enzyme cellulase-xylanase denominated ThEg3Xyn3, was constructed by gene fusion in our laboratory. The fusion was performed by binding the C-terminus of an endoglucanase from Trichoderma harzianum to the N-terminus of a xylanase of the same fungus, separated by a linker. The chimeric enzyme was recombinantly produced in Pichia pastoris and purified for kinetic and biochemical characterization. The chimera demonstrated activity of both enzymes with maximum activity at 38 °C and pH 6.0, under these conditions, cellulolytic and xylanolytic activity was greater than of the parental enzymes. The results demonstrate that the chimeric enzyme can be efficient in hydrolysis of the biomass and satisfactory for the production of ethanol by the process of simultaneous saccharification and fermentation. / O bagaço da cana-de-açúcar é um material lignocelulósico que pode ser convertido em etanol pela ação de celulases e xilanases. Essas enzimas atuam sinergicamente para converter celulose e hemicelulose em glicose. A fim de obter uma enzima capaz de realizar dupla função, uma enzima quimérica celulase-xilanase denominada ThEg3Xyn3, foi construída em laboratório. A fusão foi realizada pela ligação do C-terminal de uma endoglucanase do fungo Trichoderma harzianum ao N-terminal de uma xilanase do mesmo fungo, separadas por um linker. A enzima quimérica foi recombinantemente produzida em Pichia pastoris e purificada para caracterização cinética e bioquímica. A quimera demonstrou atividade de ambas as enzimas com atividade máxima a 38 °C e pH 6,0, sob estas condições, a atividade celulolítica e xilanolítica foi maior do que das enzimas parentais. Os resultados demonstram que a enzima quimérica pode ser eficiente na hidrólise da biomassa e satisfatória para a produção de etanol pelo processo de sacarificação e fermentação simultâneas.

Made available in DSpace on 2014-08-20T14:37:52Z (GMT). No. of bitstreams: 1 dissertacao_alceu_santos_junior.pdf: 1787319 bytes, checksum: 33ba7f2289b9ac4a868e567f7462444a (MD5) Previous issue date: 2013-02-22 / The intracellular protozoan Neospora caninum, is considered the main causative agent of abortion in cattle. Infection occurs by ingestion of sporulated oocysts in the environment, first occurs systemic parasitemy characterizing acute phase of infection and subsequent chronic phase with formation of tissue cysts, thus persisting the infected and the asymptomatic host. Diagnosis is made by serologic tests. Currently, there are no data to ensure the effectiveness of commercial vaccine available for cattle. Apical complex antigens of the parasite are being studied, since they have an important role in infection. The rhoptries, secretory glands present in this region of the parasite N. caninum, play an important role in invasion and formation of parasitophago vacuoles, these properties have generated interest in its use in experimental vaccine formulations. Experimentally it showed partial results of protection in challenge, when fused to other proteins of this protozoan, the protection was increased, suggesting that antigens fusion is effective for protection against N. caninum. This work produced a new chimeric antigen, originated from the fusion of ROP² N. caninum with the B subunit of heat labile enterotoxin of Escherichia coli. The construction of the chimera was accomplished by cloning in sequence where ROP² gene was inserted directly into the N-terminus of LTB. The construction ROP²/LTB was expressed in E. coli strain BL 21 (DE3) StarTM where it presented a size of approximately 24kDa. The fusion antigen did not impair the antigenicity when tested against positive bovine serum by immunofluorescence, the Western blot technique, therefore, show great potential for use as a recombinant vaccine. / O protozoário intracelular Neospora caninum, é considerado principal agentes causadores de aborto em bovinos. A infecção ocorre pela ingestão de oocistos esporulados no ambiente, inicialmente ocorre parasitemia sistêmica caracterizando fase aguda da infecção e posteriormente fase crônica com formação de cistos teciduais, permanecendo assim o hospedeiro infectado e assintomático. O diagnóstico é feito através de provas sorológicas. Atualmente, não há dados que assegurem a eficácia da vacina comercial disponível para bovinos. Antígenos do complexo apical do parasito estão sendo estudados, pois apresentam papel importante na infecção. As roptrias, glândulas secretoras presente nesta região do parasito N. caninum, desempenham papel importante na invasão e formação do vacúolo parasitófago, essas propriedades produziram interesse na sua utilização em formulações de vacina experimentais. Experimentalmente apresentou resultados parciais de proteção ao desafio, quando fusionada a outras proteínas deste protozoário, aumentou a proteção, sugerindo que fusão de antígenos é eficiente para proteção contra N. caninum. O presente trabalho produziu um novo antígeno quimérico, originado da fusão entre ROP² de N. caninum com a subunidade B, da enterotoxina termolábil de Escherichia coli. A construção da quimera foi realizada por clonagem em sequência, onde gene ROP² foi inserido diretamente na porção N-terminal da LTB. A construção, ROP²/LTB, foi expressa em cepa E. coli BL 21 (DE3) StarTM onde apresentou tamanho de aproximadamente 24kDa. A fusão de antígeno não prejudicou a antigenicidade quando testado frente a soro bovino positivo por Imunofluorescência, na técnica de Western blot, portanto, apresentando grande potencial para ser utilizado como vacina recombinante.

Ce travail de thèse sur la parure dans la culture étrusque s’inscrit dans un domaine de recherche particulièrement fécond. En effet, les études récentes dans le domaine de l’Antiquité se sont volontiers portées sur ce champ qu’est le corps, qu’il fût vêtu ou dénudé, sous toutes ses modalités, les plus matérielles comme les plus abstraites, dans son intériorité comme dans son actualisation sous de multiples aspects. En cela, elles ont suivi la voie ouverte par les sciences sociales et historiques depuis au moins trois décennies.Compte tenu de l’état des sources, cette recherche se penche plus particulièrement sur les monuments figurés ou les artéfacts, dans une démarche comparatiste, en utilisant les outils des sciences sociales, de l’anthropologie notamment, pour définir notre objet d’étude. La volonté était, en effet, dès l’origine de ce projet, de ne se limiter ni à une période, ni à un territoire, ni à un genre, mais bel et bien d’étudier la parure en diachronie, de manière à en saisir les articulations et les traits saillants qui font le propre de la culture étrusque. Notre objectif est ainsi de déceler s’il existe un véritable système de la parure dans l’aire étrusque. Pour ce faire, notre enquête débute par une étude linguistique, pour retrouver, sous les pratiques, les mots de la parure, puis nous interrogeons les formes en relation avec la cosmologie étrusque, et les classons, enfin les fonctions, selon qu’on considère la parure comme un langage, ou comme un système d’action, dans une perspective d’anthropologie de la figuration. / This research work on adornment in Etruscan culture is part of a particularly fruitful domain. Recent studies in Antiquity have focused on the field of the body, in its interiority as well as in its actualization ,whether dressed or naked and in all its forms : from the most material ones to the most abstract ones. In this respect, these studies have followed the path opened by the social and historical sciences for at least three decades.Given the state of the sources, this research focuses more particularly on figurative monuments or artifacts in a comparative approach to define our subject of study, using tools from the social sciences, especially anthropology. From the very beginning of this project, our intention has not been to limit our work to a period, a territory or a genre but to study adornment diachronically in order to grasp its articulations and the salient features that are characteristic of Etruscan culture. Our objective is to detect whether a real system of adornment prevailed in the Etruscan area. To do this, our investigation begins with a linguistic study to find the words of adornment underneath practices and customs. Then we question the forms in relation to Etruscan cosmology, and classify them. Finally, we analyze the functions, according to whether we consider adornment as a language, or as a system of actions, in a perspective of an anthropology of figuration

Most patients diagnosed with cancer will receive systematic chemotherapy at some point during their illness, which almost always cause severe side effects for the patients such as, anemia, nausea and vomiting. The problems with today’s chemotherapy is not only that it cause severe side effects, but also that the cancer may develop resistance to the therapy, which is why the development of a new type of therapeutic agent is in dire need. The ubiquitin proteasome system (UPS) is a vital machinery for the cancer cells to maintain protein homeostasis, which also make them vulnerable to any disruption of this system. In recent years, a new technology has been developed that utilize the UPS by chemically bringing an E3 ubiquitin ligase into close proximity of a protein of choice and tagging the protein with ubiquitin for degradation. This technology is called proteolysis targeting chimera (PROTAC). In this project, we managed to theoretically develop a new type of cancer therapeutic agent, that utilize the PROTAC system together with the first-in-class proteasome regulatory subunit, POH1, inhibitor Capzimin as a warhead. By using Capzimin as a warhead it should be possible to polyubiquitinate POH1, and thus induce proteotoxic stress in the cancer cells to trigger apoptosis. This theoretically developed drug is therefore called Capzimin-PROTAC, which should be able to trigger apoptosis in cancer cells, and at the same time being relatively safe to normal healthy cells.

Contents of the present thesis were published in the following articles. 1. Suzuki S, Mori K, Higashino A, Iwasaki Y, Yasutomi Y, Maki N, Akari H. 2016. Persistent replication of a hepatitis C virus genotype 1b-based chimeric clone carrying E1, E2 and p6 regions from GB virus B in a New World monkey. Microbiol Immunol 60:26-34. Copyright © 1999-2016 John Wiley & Sons, Inc.2. Yoshida T, Suzuki S, Iwasaki Y, Kaneko A, Saito A, Enomoto Y, Higashino A, Watanabe A, Suzuki J, Inoue K, Kuroda T, Takada M, Ito R, Ito M, Akari H. 2013. Efficient in vivo depletion of CD8+ T lymphocytes in common marmosets by novel CD8 monoclonal antibody administration. Immunol Lett 154:12-17.Copyright © 2013 Elsevier B. V. / 京都大学 / 0048 / 新制・課程博士 / 博士(理学) / 甲第19546号 / 理博第4206号 / 新制||理||1604(附属図書館) / 32582 / 京都大学大学院理学研究科生物科学専攻 / (主査)教授 明里 宏文, 教授 岡本 宗裕, 教授 中村 克樹 / 学位規則第4条第1項該当 / Doctor of Science / Kyoto University / DFAM

No description available.